UConn & UNC at Chapel Hill Research Team Launch Drug Therapy Venture at UConn’s Technology Incubation Program
Researchers from the University of Connecticut and the University of North Carolina at Chapel Hill have been collaborating on developing specifically designed nanoparticles for targeted drug delivery. The team have launched a new venture based on the research. Located...
Trump Administration Sues Gilead for Patient Infringement
The Trump administration has sued Gilead Sciences alleging patent infringement over its drugs to prevent the spread of HIV. The lawsuit alleges that Gilead has benefited from massive profits thanks to Truvada and Descovy drugs that in fact have been patented by the...
Study Evidences Superior Technology to Assess NASH During Clinical Trials
An international team of pathologists and hepatologists from China, Singapore, Europe and America concluded a study successfully testing qFIBS, a novel automated algorithm developed by HistoIndex which successfully distinguished different grades and stages of...
Does a Non-Opioid Pain Medication Work? A Current Bunion Surgery Clinical Trial May Provide Some Answers
Lotus Clinical Research has a clinical trial testing its non-opioid pain medication called CA-008 during an elective unilateral transpositional first metatarsal osteotomy for the correction of hallux valgus deformity (bunionectomy), also known as bunion surgery....
Vanderbilt University Recruits Glaucoma Patients for Allergan Medication Using Novel ‘Dropless’ Method
Vanderbilt University Medical Center seeks patients diagnosed with Ocular Hypertension or Angle Glaucoma for a study testing a new dropless delivery method for eye pressure. Called the “Triton” research study, it entails 36 visits over a 30 month period. The Study The...
Clinical Trials and Research News Weekly Roundup | 11-11-2019 S1 E17
https://www.youtube.com/watch?v=63Nde0nQ-Uk Join us as we go over our top stories from the week: CRO Clinipace Raises $4.2M in Quest for $10M and More Employees as They Continue to Grow. Can PPD’s SiteCoach help Overcome the ‘One and Done’ Challenge with Clinical...
Utah Life Sciences Summit 2019
Previously, TrialSite News covered the exciting expansion of life sciences in Utah. With newfound connections made to Utah’s most prominent life science leaders, it was our pleasure to attend the 2019 Utah Life Sciences Summit held November 7th, 2019, at the Salt Lake...
NEWS
Popular Posts
KOL Hepatologist to Discuss Clinical Trial Results for Patients with Alcoholic Hepatitis
Tarek I Hassanein, MD, an expert hepatologist and clinical investigator, presents for DURECT Corporation as Key Opinion Leader or “KOL” on the results of a Phase 2a clinical trial of DUR-928 in patients with alcoholic hepatitis (AH). Consider attending the...
Real-World Data Shows Results of Ranibizumab in the OCEAN Study for Treatment of Retinal Vein Occlusion
The non-interventional OCEAN Study evaluated frequency and monitoring injections for retinal vein occlusion (RVO) in routine practice in Germany. The Novartis-sponsored real-world study revealed that patients with RVO in routine practice in Germany...
Cancer Study Terminated at Rensselaer Polytechnic Institute’s Biomedical Research Labs due to Quality Issues
Rensselaer Polytechnic Institute’s (RPI) biomedical research labs had a study terminated according to an animal activist group report filed with a federal agency overseeing the welfare of animal in research labs. What Happened? Apparently an in-house veterinarian...
Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial
Fred Hutchinson Cancer Research Center is an amazing place. At the forefront of combating cancer, recently they recently served as a clinical investigational site for a clinical trial for an investigational CAR-T cell treatment targeting multiple myeloma. The Patient...
Are Young-Blood Transfusions Helping Seniors Age Less?
Can younger blood help older people feel good, improve skin, enhance athleticism and fight disease onset? That is the opportunity being sold by entrepreneur Jesse Karmazin, MD. Princeton University and Stanford Medical School graduate and unlicensed MD Jesse...
Colombian Woman’s Genes Offer New Clues to Staving Off Alzheimer’s
In 2016, a 73-year-old woman from Medellín, Colombia, flew to Boston so researchers could scan her brain, analyze her blood, and pore over her genome. She carried a genetic mutation that had caused many in her family to develop dementia in middle age. But for decades,...
Fred Hutchinson CAR-T Cell Therapy Shows Results for Patient in Phase I Clinical Trial
Fred Hutchinson Cancer Research Center is an amazing place. At the forefront of combating cancer, recently they recently served as a clinical investigational site for a clinical trial for an investigational CAR-T cell treatment targeting multiple myeloma. The Patient...
Center for Immunotherapy, Roswell Park Stands Out
Roswell Park Comprehensive Cancer Center (Roswell Park) believes it is in a unique position to lead innovative immune-oncology clinical research. The Center for Immunotherapy at Roswell Park is product to be among only 28 elite universities and cancer centers in North...
Privately-Held Segal Trials Supports Usona Institute’s PSIL201 Clinical Trial Testing the Use of Psilocybin for Major Depression
Segal Trials, a privately held network of research sites throughout South Florida and South Carolina conducting Phase I-IV clinical trials, has been named one of seven sites to initiate a Phase II study of psilocybin—a psychedelic prodrug compound—for major depressive...
Audit of SUNY Upstate Medical University Showcases Questionable Leadership Decisions and the Ensuing Consequences
New York Comptroller Thomas DiNapoli followed the lead of Syracuse.com’s journalist James T. Mulder in his audit of SUNY Upstate Medical University. His series of investigative news stories led DiNapoli to uncover the “egregious...
Niloufer Hospital Hyderabad Orders Probe into Improper Clinical Trials
The Telangana Health Department ordered a probe into the alleged illegal clinical trials at government-run Niloufer Hospital in Hyderabad. It is alleged that some hospital physicians colluded with pharmaceutical companies to conduct clinical trials in violation of...
Peanut Allergy Therapy – Millions for Peanuts
Peanuts are a uniquely dangerous legume. A small fragment of one can kill an allergic person. Even if that person is resuscitated, it’s possible to have permanent brain damage. These severe allergic reactions are relatively rare but difficult to predict. One time, you...
